Liverpool ChiroChem

About:

Liverpool ChiroChem manufactures and supplies specialist building blocks for pharmaceutical research and biotechnology.

Website: http://www.liverpoolchirochem.com/

Twitter/X: chirochem

Top Investors: Deepbridge Capital, Praetura Ventures, Northern Powerhouse Investment Fund, NPIF Maven Equity Finance

Description:

Liverpool ChiroChem (LCC) is a chemistry-based CRO that produces chiral small molecules for biotech/pharmaceutical R&D. Their specialist products can be used as building blocks, fragments and screening compounds to enable small molecule drug discovery. their chemical technologies provide efficient access to novel chiral building blocks for hit identification and hit-to-lead optimization. LCC’s catalytic methods give access to a wide range of chiral amines in excellent enantiomeric purity. Their initial focus is on the production and supply of chiral piperidines and other sp3-rich nitrogen heterocycles , which are of great importance to drug discovery and development due to their excellent pharmacokinetic properties e.g. improved solubility and bioavailability. LCC's technologies were developed through years of research in the areas of asymmetric hydrogenation and Pd-coupling. LCC now provide collaborate services with their customers to optimise key steps in synthetic routes.